Author:
Kenmochi Takashi,Han Duck-Jong,Ko Young Min
Reference16 articles.
1. Choi BH, Choi HK, Cho Jung JH, Choi JY, Shin S, Kim YH, Han DJ. How to reduce lethal infectious complications in ABO-incompatible kidney transplantation. Transplant Proc. 2015;47(3):653–9.
2. Baek CH, Yang WS, Park KS, Han DJ, Park JB, Park SK. Infectious risks and optimal strength of maintenance immunosuppressants in rituximab-treated kidney transplantation. Nephron Extra. 2012;2(1):66–75.
3. Kwon H, Kim YH, Choi JY, Sung S, Jung JH, Park S-K, Han DJ. Analysis of 4000 kidney transplantations in a single center: across immunological barriers. Medicine (Baltimore). 2016;95(32):e4249.
4. Choi BH, Han DJ. Ongoing higher infection rate in ABO-incompatible kidney transplant recipient: is it a serious problem? A single-center experience. Ann Surg Treat Res. 2016;91(1):37–44.
5. Kim KY, Kim JY, Kim SH, Kim DH, Lim SJ, Shin S, Kim YH, Jung JH, Park SK, Kwon H, Han DJ. Acute rejection and infectious complications in ABO- and HLA-incompatible kidney transplantations. Ann Transplant. 2020;25:e927420.